Exclusive: U.S. test of AstraZeneca COVID-19 vaccine may resume this sources week
AstraZeneca Plc’s AZN.L COVID-19 vaccine test in america is anticipated to resume as soon as this week following the U.S. Food and Drug management finished its summary of an illness that is serious a research participant, four sources told Reuters.
AstraZeneca’s large, late-stage U.S. test is on hold since Sept. 6, after having a participant when you look at the company’s UK trial dropped sick using what ended up being suspected to be an uncommon spinal inflammatory disorder called transverse myelitis.
The sources, who have been briefed in the matter but asked to keep anonymous, stated they’ve been told the trial could resume later on this week. It absolutely was confusing the way the Food And Drug Administration would characterize the condition, they stated. 자세히 보기 →